Virtra Sets Third Quarter 2026 Conference Call For Thursday, November 12, 2026 At 4:30 P.M. ET
VirTra management will host the presentation, followed by a question-and-answer period.
Date: Thursday, November 12, 2026
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
U.S. dial-in: 1-877-300-8521
International dial-in: 1-412-317-6026
Conference ID: 10212841
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 949-574-3860.
The conference call will be broadcast live and available for replay here and via the investor relations section of the Company's website.
A replay of the call will be available after 7:30 p.m. Eastern time on the same day through November 26, 2026.
Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 10212841
About VirTra, Inc.
VirTra is a global leader in immersive, simulation-based training solutions for de-escalation, judgmental use of force and weapons proficiency. Serving law enforcement, military, educational and commercial organizations, VirTra combines advanced technology, realistic scenarios and proprietary training tools to help users improve decision-making, strengthen readiness and perform more effectively under pressure. Since 1993, VirTra has remained committed to its mission of saving lives by preparing professionals for the complex, high-stakes situations they may face in the real world.
Investor Relations Contact:
Matt Glover and Greg Bradbury
Gateway Group, Inc.
...
949-574-3860
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment